Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions

NANot yet recruitingINTERVENTIONAL

Enrollment

218

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

May 31, 2026

Conditions

Coronary Artery Disease

Interventions

DEVICE

Bingo® Paclitaxel coated balloon

Treat the main vessel and side branch of bifurcation lesion with drug-eluting balloon

DEVICE

Xience® Alpine Everolimus Eluting Coronary Stent System

Treat the main vessel of bifurcation lesion with drug-eluting stent, and treat the side branch with uncoated balloon or drug-eluting stent

All Listed Sponsors

lead

Yinyi(Liaoning) Biotech Co., Ltd.

INDUSTRY

NCT06441539 - Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions | Biotech Hunter | Biotech Hunter